178 related articles for article (PubMed ID: 24769442)
41. Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim.
Sheridan C; Brumatti G; Martin SJ
J Biol Chem; 2008 Aug; 283(32):22128-35. PubMed ID: 18508762
[TBL] [Abstract][Full Text] [Related]
42. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
[TBL] [Abstract][Full Text] [Related]
43. Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability.
Wu DW; Chen CY; Chu CL; Lee H
Oncogene; 2016 Feb; 35(5):621-30. PubMed ID: 25915848
[TBL] [Abstract][Full Text] [Related]
44. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
[TBL] [Abstract][Full Text] [Related]
45. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.
Wang YH; Cao YW; Yang XC; Niu HT; Sun LJ; Wang XS; Liu J
Asian Pac J Cancer Prev; 2014; 15(3):1321-6. PubMed ID: 24606459
[TBL] [Abstract][Full Text] [Related]
46. CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies.
Chen S; Dai Y; Pei XY; Myers J; Wang L; Kramer LB; Garnett M; Schwartz DM; Su F; Simmons GL; Richey JD; Larsen DG; Dent P; Orlowski RZ; Grant S
Cancer Res; 2012 Aug; 72(16):4225-37. PubMed ID: 22693249
[TBL] [Abstract][Full Text] [Related]
47. Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.
Jazirehi AR; Baritaki S; Koya RC; Bonavida B; Economou JS
Cancer Res; 2011 Feb; 71(4):1406-17. PubMed ID: 21159666
[TBL] [Abstract][Full Text] [Related]
48. Role of Bim in regulating CD8+ T-cell responses during chronic viral infection.
Grayson JM; Weant AE; Holbrook BC; Hildeman D
J Virol; 2006 Sep; 80(17):8627-38. PubMed ID: 16912311
[TBL] [Abstract][Full Text] [Related]
49. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival.
Yang W; Klaman LD; Chen B; Araki T; Harada H; Thomas SM; George EL; Neel BG
Dev Cell; 2006 Mar; 10(3):317-27. PubMed ID: 16516835
[TBL] [Abstract][Full Text] [Related]
50. Regulation of mRNA export through API5 and nuclear FGF2 interaction.
Bong SM; Bae SH; Song B; Gwak H; Yang SW; Kim S; Nam S; Rajalingam K; Oh SJ; Kim TW; Park S; Jang H; Lee BI
Nucleic Acids Res; 2020 Jun; 48(11):6340-6352. PubMed ID: 32383752
[TBL] [Abstract][Full Text] [Related]
51. BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.
Nordigården A; Kraft M; Eliasson P; Labi V; Lam EW; Villunger A; Jönsson JI
Blood; 2009 Mar; 113(10):2302-11. PubMed ID: 19064725
[TBL] [Abstract][Full Text] [Related]
52. The Erk2 MAPK regulates CD8 T cell proliferation and survival.
D'Souza WN; Chang CF; Fischer AM; Li M; Hedrick SM
J Immunol; 2008 Dec; 181(11):7617-29. PubMed ID: 19017950
[TBL] [Abstract][Full Text] [Related]
53. Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma.
Marek LA; Hinz TK; von Mässenhausen A; Olszewski KA; Kleczko EK; Boehm D; Weiser-Evans MC; Nemenoff RA; Hoffmann H; Warth A; Gozgit JM; Perner S; Heasley LE
Mol Cancer Res; 2014 Oct; 12(10):1460-9. PubMed ID: 24966347
[TBL] [Abstract][Full Text] [Related]
54. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression.
Collins NL; Reginato MJ; Paulus JK; Sgroi DC; Labaer J; Brugge JS
Mol Cell Biol; 2005 Jun; 25(12):5282-91. PubMed ID: 15923641
[TBL] [Abstract][Full Text] [Related]
55. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
[TBL] [Abstract][Full Text] [Related]
56. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
[TBL] [Abstract][Full Text] [Related]
57. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.
Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ
Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305
[TBL] [Abstract][Full Text] [Related]
58. c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1.
Campone M; Noël B; Couriaud C; Grau M; Guillemin Y; Gautier F; Gouraud W; Charbonnel C; Campion L; Jézéquel P; Braun F; Barré B; Coqueret O; Barillé-Nion S; Juin P
Mol Cancer; 2011 Sep; 10():110. PubMed ID: 21899728
[TBL] [Abstract][Full Text] [Related]
59. 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.
Lee HW; Park SJ; Choi BK; Kim HH; Nam KO; Kwon BS
J Immunol; 2002 Nov; 169(9):4882-8. PubMed ID: 12391199
[TBL] [Abstract][Full Text] [Related]
60. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
Hall CP; Reynolds CP; Kang MH
Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
